Federal regulators have failed in their bid to punish Bayer Corp. for what they called overinflated claims about a probiotic supplement.
U.S. District Judge Jose Linares of the District of New Jersey on Sept. 24 denied the Federal Trade Commission’s motion to hold Bayer in contempt of a 2007 consent order for touting Phillips Colon Health. In the 2007 order, the company was directed to dial back advertising claims made in connection with a different product.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
